Clinical trial

A Study to Evaluate Subjects With Turner Syndrome Treated With Growth Hormone

NCT00097552 · Genentech, Inc., Industry · Completed

Key facts

NCT number NCT00097552
Title A Study to Evaluate Subjects With Turner Syndrome Treated With Growth Hormone
Official title Characterization of Subjects With Turner Syndrome Treated With Growth Hormone in the National Cooperative Growth Study (NCGS)
Lead sponsor Genentech, Inc., Industry
Status Completed
Study type Observational
Conditions Turner Syndrome
Enrollment 1,696
Start date May 1, 1997
Primary completion Jul 1, 2010
Completion Jul 1, 2010
First posted Nov 25, 2004
Last update posted Nov 14, 2012

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies